BMS-181184 is a water-soluble pradimicin derivative with a broad antifungal spectrum in vitro and demonstrable efficacy against systemic infections with Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus in normal and cyclophosphamide-treated immunosuppressed mice.
No takes yet. Share an insight, caveat, or question.
OKI et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: